{"organizations": [], "uuid": "73ad1c73fefb9c7823f0514570677bc00910a11c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-aveo-says-eusa-pharma-granted-posi/brief-aveo-says-eusa-pharma-granted-positive-nice-recommendation-for-fotivda-idUSFWN1Q210G", "country": "US", "domain_rank": 408, "title": "BRIEF-AVEO Says EUSA Pharma Granted Positive NICE Recommendation For Fotivda", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-12T14:26:00.000+02:00", "replies_count": 0, "uuid": "73ad1c73fefb9c7823f0514570677bc00910a11c"}, "author": "", "url": "https://www.reuters.com/article/brief-aveo-says-eusa-pharma-granted-posi/brief-aveo-says-eusa-pharma-granted-positive-nice-recommendation-for-fotivda-idUSFWN1Q210G", "ord_in_thread": 0, "title": "BRIEF-AVEO Says EUSA Pharma Granted Positive NICE Recommendation For Fotivda", "locations": [], "entities": {"persons": [{"name": "fotivda", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "eusa pharma granted positive nice", "sentiment": "negative"}, {"name": "eusa pharma granted positive nice recommendation for fotivda", "sentiment": "negative"}, {"name": "aveo pharmaceuticals inc", "sentiment": "none"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 26 PM / in 23 minutes BRIEF-AVEO Says EUSA Pharma Granted Positive NICE Recommendation For Fotivda Reuters Staff 1 Min Read \nFeb 12 (Reuters) - Aveo Pharmaceuticals Inc: \n* AVEO ANNOUNCES EUSA PHARMA GRANTED POSITIVE NICE RECOMMENDATION FOR FOTIVDA® (TIVOZANIB) AS FIRST LINE TREATMENT FOR ADVANCED RENAL CELL CARCINOMA \n* AVEO PHARMACEUTICALS INC - ‍RECOMMENDATION TRIGGERS $2MLN MILESTONE PAYMENT FROM EUSA TO AVEO​ Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-02-12T14:26:00.000+02:00", "crawled": "2018-02-12T14:54:02.000+02:00", "highlightTitle": ""}